诺舒阻抗子宫内膜切除系统治疗月经过多151例分析

发布时间：2018-01-14 04:30

本文关键词：诺舒阻抗子宫内膜切除系统治疗月经过多151例分析　出处：《中国妇产科临床杂志》2016年02期 　论文类型：期刊论文

【摘要】：目的探讨诺舒阻抗子宫内膜切除系统(NovaSure)治疗月经过多的疗效及并发症。方法回顾性分析2012年2月至2014年12月行诺舒阻抗子宫内膜切除术治疗月经过多患者151例的临床资料及术后随访情况。结果 151例患者平均年龄(43.62±6.16)岁,84.77%(128/151)的患者合并贫血,20.53%(31/151)的患者合并严重内科疾病。平均宫腔深度(8.83±1.80)cm;平均手术时间(89.78±21.14)s,术中出血量均小于10ml;术后平均住院时间为(48.00±6.50)h,术后疼痛发生率为20.53%(31/151),阴道排液率为81.46%(123/151);术后随访3~37个月,平均随访(20.44±8.17)个月,有效率为94.04%(142/151),闭经率为53.64%(81/151),子宫切除率为2.65%(4/151)。结论 NovaSure治疗月经过多近期安全有效,但更远期效果仍需深入研究。
[Abstract]:Objective to investigate the NovaSure endometrial ablation system impedance (NovaSure) effect and complications of treatment of menorrhagia. Methods Retrospective analysis of clinical data from February 2012 to December 2014 of navosure impedance endometrial resection in the treatment of 151 cases of patients with excessive menstruation and postoperative follow-up. The average age of the results of 151 patients (43.62 + 6.16), 84.77% (128/151) of the patients with anemia, 20.53% (31/151) in patients with severe internal diseases. The average depth of the uterine cavity (8.83 + 1.80) cm; the average operation time (89.78 + 21.14) s, the amount of bleeding was less than 10ml; the average postoperative hospitalization time was (48 + 6.50) H postoperative pain, the incidence rate was 20.53% (31/151), vaginal discharge rate was 81.46% (123/151); postoperative follow-up of 3~37 months, the average follow-up (20.44 + 8.17) months. The rate was 94.04% (142/151), the amenorrhea rate was 53.64% (81/ 151), hysterectomy rate was 2.65% (4/151) conclusion NovaSure. It is safe and effective to treat menorrhagia in the near future, but the more long-term effect still needs to be studied in depth.

【作者单位】：广西壮族自治区人民医院妇产科;
【分类号】：R713.4
【正文快照】： 月经过多(menorrhagia)也称月经出血过多(heavy　menstrual　bleeding,HMB),是异常子宫出血(abnormal　uterine　bleeding,AUB)最常见的表现。月经过多常用的治疗方法有激素治疗、诊刮、子宫内膜切除术及子宫切除术。激素治疗时间长,效果差,停药后易复发,不良反应重。诊刮可

【相似文献】